Stockscreener 앱 받기
147.64
0.52%
0.76
전일 마감가:
$146.88
열려 있는:
$146.04
하루 거래량:
163.42K
Relative Volume:
0.46
시가총액:
$4.27B
수익:
$290.51M
순이익/손실:
$89.16M
주가수익비율:
49.38
EPS:
2.99
순현금흐름:
$119.18M
1주 성능:
+1.22%
1개월 성능:
+0.02%
6개월 성능:
-14.83%
1년 성능:
-25.52%
1일 변동 폭
$145.78
$147.98
1주일 범위
$143.09
$152.04
52주 변동 폭
$122.80
$207.84
Krystal Biotech Inc Stock (KRYS) Company Profile
명칭
Krystal Biotech Inc
전화
(412) 586-5830
주소
2100 WHARTON STREET, PITTSBURGH, PA
KRYS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
147.64 | 4.25B | 290.51M | 89.16M | 119.18M | 2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-05 | 개시 | Jefferies | Buy |
| 2024-08-06 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-11-20 | 개시 | Goldman | Buy |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-10-12 | 개시 | Citigroup | Buy |
| 2023-09-07 | 개시 | Berenberg | Buy |
| 2023-04-18 | 개시 | Stifel | Buy |
| 2023-02-28 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-08-25 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-01-18 | 개시 | BofA Securities | Buy |
| 2021-07-20 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-09-18 | 개시 | B. Riley FBR | Buy |
| 2020-06-04 | 개시 | Evercore ISI | Outperform |
| 2019-09-24 | 개시 | Goldman | Neutral |
| 2019-08-06 | 재확인 | H.C. Wainwright | Buy |
| 2019-06-24 | 재확인 | Chardan Capital Markets | Buy |
| 2019-06-24 | 재확인 | H.C. Wainwright | Buy |
| 2019-05-30 | 개시 | Guggenheim | Buy |
| 2018-09-11 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Krystal Biotech Inc 주식(KRYS)의 최신 뉴스
Best data tools to analyze Krystal Biotech Inc. stock2025 Institutional Moves & Weekly Market Pulse Updates - Newser
Analyzing recovery setups for Krystal Biotech Inc. investors2025 Key Lessons & Weekly Breakout Stock Alerts - Newser
Published on: 2025-08-28 00:28:10 - Newser
Published on: 2025-08-27 22:17:20 - Newser
Applying big data sentiment scoring on Krystal Biotech Inc.Portfolio Return Summary & Fast Gain Stock Trading Tips - Newser
Is Krystal Biotech Inc. stock poised for growthJuly 2025 Short Interest & Low Risk High Reward Ideas - Newser
Ranking Krystal Biotech Inc. among high performing stocks via toolsJuly 2025 Trends & Free Real-Time Market Sentiment Alerts - Newser
Krystal Biotech Inc. Building a Base Near Support getLinesFromResByArray error: size == 0 - newsyoung.net
Should you wait for a breakout in Krystal Biotech Inc.Forecast Cut & Stock Market Timing Techniques - Newser
Using data models to predict Krystal Biotech Inc. stock movementJuly 2025 PreEarnings & Verified Momentum Stock Watchlist - Newser
Will Krystal Biotech Inc. stock recover after recent dropJuly 2025 Breakouts & Free Reliable Trade Execution Plans - Newser
Is this a good reentry point in Krystal Biotech Inc.2025 Year in Review & Momentum Based Trading Ideas - Newser
Will Krystal Biotech Inc. price bounce be sustainableQuarterly Performance Summary & Fast Moving Trade Plans - Newser
Analyzing net buyer seller activity in Krystal Biotech Inc.Portfolio Value Report & Stepwise Swing Trade Plans - Newser
Order flow analysis tools used on Krystal Biotech Inc.Gap Down & AI Powered Trade Plan Recommendations - Newser
Using flow based indicators on Krystal Biotech Inc.2025 Key Lessons & Free Verified High Yield Trade Plans - Newser
What MACD and RSI say about Krystal Biotech Inc.Weekly Trade Report & Community Shared Stock Ideas - Newser
How to track smart money flows in Krystal Biotech Inc.2025 Market Trends & Weekly Consistent Profit Watchlists - Newser
Quantitative breakdown of Krystal Biotech Inc. recent moveEarnings Summary Report & Free Weekly Chart Analysis and Trade Guides - Newser
Combining machine learning predictions for Krystal Biotech Inc.Quarterly Portfolio Report & Entry and Exit Point Strategies - Newser
Krystal Biotech Inc. stock retracement – recovery analysisOil Prices & Reliable Entry Point Trade Alerts - Newser
Has Krystal Biotech Inc. found a price floor2025 Volume Leaders & Intraday High Probability Setup Alerts - Newser
Understanding Krystal Biotech Inc.’s price movement2025 Earnings Surprises & Stepwise Trade Signal Guides - Newser
Using data filters to optimize entry into Krystal Biotech Inc.Trade Analysis Report & Verified Chart Pattern Trade Signals - Newser
How to monitor Krystal Biotech Inc. with trend dashboardsAnalyst Downgrade & Stepwise Entry and Exit Trade Signals - Newser
How to use Fibonacci retracement on Krystal Biotech Inc.Weekly Stock Report & High Yield Stock Recommendations - Newser
Key metrics from Krystal Biotech Inc.’s quarterly data2025 Institutional Moves & Real-Time Stock Movement Alerts - Newser
Published on: 2025-08-25 22:18:19 - Newser
Krystal Biotech Inc. Building a Base Near SupportWeekly Loss Report & Expert Approved Trade Ideas - kangso.co.kr
Building trade automation scripts for Krystal Biotech Inc.July 2025 Trends & Weekly Market Pulse Alerts - Newser
Support Zone Holds Steady for Krystal Biotech Inc. After DipJuly 2025 PostEarnings & Short-Term Trading Alerts - beatles.ru
Is Krystal Biotech Inc. stock undervalued right nowWeekly Trend Summary & Breakout Confirmation Alerts - theviewers.co.kr
Krystal Biotech adjusts pipeline to prioritize inhaled antitumor agent - MSN
Krystal Biotech shares rise 3.58% intraday after Chardan trims price target to $216. - AInvest
Krystal Biotech: A "Strong Buy" Despite KB707 Melanoma Tumor Targeting Update (KRYS) - Seeking Alpha
Chardan Trims Price Target on Krystal Biotech to $216 From $219, Keeps Buy Rating - MarketScreener
What is the earnings history of Krystal Biotech Inc.July 2025 Pullbacks & Smart Allocation Stock Reports - theviewers.co.kr
Krystal Biotech Inc. Nearing Breakout Level After BounceJuly 2025 Momentum & High Conviction Buy Zone Alerts - 더경남뉴스
Krystal Biotech prioritizes inhaled cancer drug (KRYS:NASDAQ) - Seeking Alpha
Krystal Biotech to Prioritize Inhaled KB707 for Treatment of Non-Small Cell Lung Cancer - MarketScreener
Krystal Biotech granted FDA meeting for KB707 for October - MarketScreener
Krystal Biotech advances lung cancer therapy to FDA discussions - Investing.com
Krystal Biotech Provides Development Update on Inhaled KB707 for Non-Small Cell Lung Cancer Treatment - Quiver Quantitative
Krystal Biotech Announces Update on Development Plans for Oncolo - GuruFocus
Krystal Biotech Inc (KRYS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.98%
8.06%
자본화:
|
볼륨(24시간):